Value of serum MCP-1 and sICAM-1 in neonates with hypoxic-ischemic encephalopathy

VernacularTitle:新生儿缺氧缺血性脑病血清单核细胞趋化蛋白-1和可溶性细胞黏附分子-1变化的临床意义
Author: Helian WANG ; Feng LI
Publication Type:Journal Article
Keywords: Hypoxia-ischemia encephalopathy; MCP-1; sICAM-1; Brain injury
From: Chinese Journal of Primary Medicine and Pharmacy 2015;22(4):580-582
CountryChina
Language:Chinese
Abstract: Objective To study the levels of serum MCP-1 and sICAM-1 in neonates with hypoxic-ischemic encephalopathy(HIE) and to explore the clinical value of serum MCP-1 and sICAM 1 for judgment and prognosis of brain damage in neonates with HIE.Methods The levels of serum MCP-1 and sICAM-1 in the 1 st and 7th day after birth of the 53 cases term infant with HIE(29 cases were mild HIE,15 cases were moderate HIE and 9 cases were severe HIE) were measured by enzyme linked immunosorbent assay (ELISA),and compared with 20 cases of normal newborns.Results The levels of serum MCP-1 and sICAM-1 in mild,moderate and severe HIE groups were all significantly higher than those in controls(P ＜ 0.05) ;With increasing of the degree of brain injury,the levels of serum MCP-1 and sICAM-1 increased (P ＜ 0.05) ; Compared with acute period (the 1 st day after birth),the levels of serum MCP-1 and sICAM-1 were clearly decreased in recovery stage(the 7th day after birth) in all HIE groups.Conclusion MCP-1 and sICAM-1 may play important roles in the pathogenesis of neonatal HIE and have clinical value in the diagnosis and treatment.